National R&D Platform for Production, Commercialization and Distribution of Innovative Biopharmaceuticals
The Bio-Hub Project takes part of the Mobilizing Agendas for Business Innovation co-financed (19,2 M€) by the Recovery and Resilience Plan (PRR).
Development and Production of Biopharmaceuticals
Phase I-IV Clinical Trials of Innovative Biological Therapies
Implementation of a biopharmaceutical production unit
The Bio-Hub Mobilizing Agenda aims to support the development and commercialization of new biological medicines.
This consortium will create an international Hub in the area of Health Sciences in Portugal, capable of producing innovative biological medicines in Europe.
It intends to make available new biological products, cement synergies between academia and the business sector, promote national talent and qualified employment while increasing the export of products to the pharmaceutical global market.